Targeted EosFP mutations at residues 41, 70, and 197 raise photoconversion contrast and cut photoblinking for more precise single-molecule imaging.
A truncated triple-splice dystrophin rAAV composition fits AAV cargo limits while reducing immune response and improving muscle function.
Engineered rAAV vectors boost Factor H expression while lowering immunogenicity for treating Factor H deficiency disorders.
Synthetic BP180 and BP230 peptide epitopes replace complex recombinant proteins for sensitive bullous pemphigoid autoantibody detection.
Modular CRISPR-Cas components expand programmable DNA and RNA editing while keeping effector complexity manageable for genome and epigenome work.
Bivalent BromoTag compounds use bump-and-hole binding to rapidly induce protein homo- or heterodimers for studying signaling and localization.
Stable placeholder-loaded MHC-I complexes enable controlled peptide exchange, reducing aggregation and background in high-throughput T-cell profiling.
Engineered Rheb mutations boost mTORC1 signaling to raise protein secretion and support serum-free mammalian cell production.
Targeted N-terminal cap mutations reduce aggregation and proteolytic degradation while improving dArmRP solubility and thermal stability.
Wild-derived APP/PSEN1 mouse models add genetic diversity and APOE to better reproduce AD neurodegeneration and brain atrophy.
Triple-splice dystrophin and utrophin constructs preserve key functional domains while fitting rAAV capacity for DMD treatment.
CRABP2 inhibition uses a synthetic retinoid and multifunctional linker to assemble precisely oriented protein megamolecules in one pot.
Developing a defined birinapant polymorph addresses stability and shelf-life needs while supporting GMP drug-product manufacturing.
V196I and G220A substitutions address low mScarlet RFP maturation efficiency while increasing cellular brightness for biological imaging.
A His operon reporter construct converts Q-tRNA sensing into fluorescence for straightforward queuosine quantification.
Chromosomally integrated fluorescent transgenes create fertile red ornamental fish on an albino background for stronger color display.
Variant survivin polypeptides and APCs help broaden HLA response coverage while expanding survivin-specific CD4+ T cells.
Ion-adsorbing zeolites remove iron ions through a semipermeable barrier, avoiding toxic chelating agents and coagulation risks in biological fluids.
Overexpressing eIF4A and eIF4G in host cells resolves low translational efficiency bottlenecks, significantly increasing recombinant protein production.
Administering an ABTB2-expressing viral vector suppresses pancreatic cancer cell proliferation, addressing limited effectiveness of conventional therapies.
Engineered non-human animals express human CACNG1 protein on skeletal muscle cells to create precise biological test models.
A synthetic copolymer maintains protein activity through hydrophilic and hydrophobic unit interactions.
Placing a mirtron in the 5'UTR resolves the trade-off between gene knockdown efficiency and transgene expression levels.
A yeast cell expression system displays human amyloid beta to identify compounds suppressing induced toxicity.
Aqueous silk polypeptide formulations use urea to maintain homogeneous distribution at high concentrations without precipitation.
Targeted knockout of YPS1-1 and YPS1-2 genes in Pichia pastoris eliminates proteolytic degradation, increasing full-length recombinant protein yield.
Recombinant spider mite silk proteins overcome domestication limits to yield antimicrobial fibers for textiles and biomedicine.
Targeting CTCF motifs with CRISPR systems engineers chromatin loops, resolving spatial co-localization assessment limits in 3D genome mapping.
Peptide SEQ ID NO: 1 inhibits COX-2 to reduce inflammatory cytokines without suppressing protective COX-1, avoiding gastrointestinal disorders.
Co-expressing prolyl-4-hydroxylase in yeast resolves low yield and improper folding of recombinant mussel byssus proteins.
Substituted amino acid residues in eight repeat motifs improve binding specificity while maintaining protein solubility.
An A56P mutant alpha-synuclein overcomes weak wild-type signals to enable effective screening of substances that mitigate neurotoxicity.
dsRNA injection replaces microsurgical gland removal to silence gene expression, enabling efficient production of all-male populations.
Spider silk fusion proteins enhance recombinant expression yields by linking solubility-enhancing moieties to target polypeptides.